Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-၂.၆၉%
၁,၀၆၈.၂၄
-၂၉.၅၇
-၂.၆၉%
—၁,၀၉၇.၈၁၁,၀၈၇.၇၆၁,၀၈၇.၇၆၁,၀၆၇.၄၂——
SIXC
Communications
SIXC
Communications
SIXC
-၀.၈၉%
၆၀၆.၅၉
-၅.၄၄
-၀.၈၉%
—၆၁၂.၀၃၆၁၂.၀၃၆၁၂.၀၃၆၀၆.၁၃——
SIXE
Energy
SIXE
Energy
SIXE
+၂.၁၉%
၁,၂၄၇.၂၁
+၂၆.၇၈
+၂.၁၉%
—၁,၂၂၀.၄၃၁,၂၂၁.၉၉၁,၂၄၇.၆၀၁,၂၂၁.၉၉——
SIXI
Industrials
SIXI
Industrials
SIXI
-၁.၈၂%
၁,၇၂၇.၅၈
-၃၁.၉၄
-၁.၈၂%
—၁,၇၅၉.၅၂၁,၇၅၄.၃၁၁,၇၅၄.၃၁၁,၇၂၃.၆၀——
SIXM
Financials
SIXM
Financials
SIXM
-၀.၃၂%
၆၂၉.၅၄
-၂.၀၀
-၀.၃၂%
—၆၃၁.၅၄၆၃၁.၂၇၆၃၃.၉၉၆၂၈.၆၃——
SIXR
Staples
SIXR
Staples
SIXR
-၀.၄၂%
၈၅၃.၆၀
-၃.၅၆
-၀.၄၂%
—၈၅၇.၁၆၈၅၈.၉၁၈၆၁.၇၁၈၅၂.၃၃——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-၁.၅၆%
၂၁၂.၀၄
-၃.၃၇
-၁.၅၆%
—၂၁၅.၄၁၂၁၅.၄၁၂၁၅.၄၁၂၁၁.၈၈——
SIXT
Technology
SIXT
Technology
SIXT
-၁.၇၈%
၃,၅၄၉.၇၆
-၆၄.၃၉
-၁.၇၈%
—၃,၆၁၄.၁၅၃,၅၅၆.၂၄၃,၅၉၈.၃၆၃,၅၁၆.၈၆——
SIXU
Utilities
SIXU
Utilities
SIXU
-၂.၄၀%
၈၈၆.၄၉
-၂၁.၈၁
-၂.၄၀%
—၉၀၈.၃၀၉၀၆.၅၅၉၀၆.၅၅၈၈၅.၈၈——
SIXV
Health care
SIXV
Health care
SIXV
-၁.၀၈%
၁,၄၆၄.၃၄
-၁၆.၀၆
-၁.၀၈%
—၁,၄၈၀.၄၀၁,၄၇၉.၅၅၁,၄၈၄.၄၃၁,၄၆၂.၅၂——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-၁.၈၄%
၂,၃၅၄.၂၅
-၄၄.၁၂
-၁.၈၄%
—၂,၃၉၈.၃၇၂,၃၇၃.၀၉၂,၃၇၃.၀၉၂,၃၅၀.၂၇——
2995:TYO
J-REX Corp
၁,၄၇၃.၀၀ JP¥
+၈.၉၅%
(+၁၂၁.၀၀) 1D
ဇန် ၉, GMT+၉ ၁၅:၁၅:၀၁  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 2995...
Volume
၀.၀၀
Dividend
၂.၆၁%
Quarterly dividend
၁၀ JP¥
P/E ratio
၂.၀၃
52-wk high
၁,၅၀၀ JP¥
52-wk low
၁,၅၀၀ JP¥
EPS
၇၂၆ JP¥
No. of employees
၄၂
News stories
From sources across the web
CNBC
CNBC
·
ပြီးခဲ့သည့် ၁၄ မိနစ်
S&P 500 manages to extend weekly win streak despite anticlimactic Trump-Xi summit
Seeking Alpha
Seeking Alpha
·
ပြီးခဲ့သည့် ၁ နာရီ
Market Leadership Is Narrow, Increasing Summer Risk
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၂ နာရီ
MercadoLibre (NasdaqGS:MELI) Valuation Check After Q1 2026 Earnings And Margin Compression
Investor's Business Daily
Investor's Business Daily
·
ပြီးခဲ့သည့် ၃ နာရီ
Stocks Near Highs But Note This; What To Do Now
About J-REX Corp
CEO-
Employees၄၂
Founded၂၀၀၂
Headquarters-
Sector-
Websitej-rex.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
၂၀၂၅ မတ်
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
Revenue
၅၁၈.၄၀ ဋေ
၅၁၈.၄၀ ဋေ
၆၅၁.၇၀ ဋေ
၆၅၁.၇၀ ဋေ
Cost of goods sold
၄၂၁.၀၀ ဋေ
၄၂၁.၀၀ ဋေ
၄၂၉.၂၅ ဋေ
၄၂၉.၂၅ ဋေ
Cost of revenue
၄၂၁.၀၀ ဋေ
၄၂၁.၀၀ ဋေ
၄၂၉.၂၅ ဋေ
၄၂၉.၂၅ ဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၆၁.၉၅ ကုဋေ
၆၁.၉၅ ကုဋေ
၇၁.၁၀ ကုဋေ
၇၁.၁၀ ကုဋေ
Operating expense
၆၁.၉၅ ကုဋေ
၆၁.၉၅ ကုဋေ
၇၁.၁၀ ကုဋေ
၇၁.၁၀ ကုဋေ
Total operating expenses
၄၈၂.၉၅ ဋေ
၄၈၂.၉၅ ဋေ
၅၀၀.၃၅ ဋေ
၅၀၀.၃၅ ဋေ
Operating income
၃၅.၄၅ ကုဋေ
၃၅.၄၅ ကုဋေ
၁၅၁.၃၅ ဋေ
၁၅၁.၃၅ ဋေ
Other non operating income
၁၀.၀၀ ကုဋေ
၁၀.၀၀ ကုဋေ
၁၂.၀၅ ကုဋေ
၁၂.၀၅ ကုဋေ
EBT including unusual items
၃၅.၃၀ ကုဋေ
၃၅.၃၀ ကုဋေ
၁၅၃.၈၀ ဋေ
၁၅၃.၈၀ ဋေ
EBT excluding unusual items
၃၅.၀၅ ကုဋေ
၃၅.၀၅ ကုဋေ
၁၅၃.၈၀ ဋေ
၁၅၃.၈၀ ဋေ
Income tax expense
၁၄.၅၅ ကုဋေ
၁၄.၅၅ ကုဋေ
၅၈.၀၀ ကုဋေ
၅၈.၀၀ ကုဋေ
Effective tax rate
၄၁.၂၂%
၄၁.၂၂%
၃၇.၇၁%
၃၇.၇၁%
Other operating expenses
-
-
-
-
Net income
၂၀.၇၅ ကုဋေ
၂၀.၇၅ ကုဋေ
၉၅.၈၀ ကုဋေ
၉၅.၈၀ ကုဋေ
Net profit margin
၄.၀၀%
၄.၀၀%
၁၄.၇၀%
၁၄.၇၀%
Earnings per share
-
-
-
-
Interest and investment income
၅.၀၀ သိန်း
၅.၀၀ သိန်း
၅.၀၀ သိန်း
၅.၀၀ သိန်း
Interest expense
-၁၀.၄၅ ကုဋေ
-၁၀.၄၅ ကုဋေ
-၉.၆၅ ကုဋေ
-၉.၆၅ ကုဋေ
Net interest expenses
-၁၀.၄၀ ကုဋေ
-၁၀.၄၀ ကုဋေ
-၉.၆၀ ကုဋေ
-၉.၆၀ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
၃၅.၆၅ ကုဋေ
၃၅.၆၅ ကုဋေ
၁၅၁.၄၅ ဋေ
၁၅၁.၄၅ ဋေ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer